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Abstract
Background: Development of simple instruments for the determination of the level of adherence in patients with
high blood pressure is the subject of ongoing research. One such instrument, gaining growing popularity
worldwide, is the Hill-Bone Compliance to High Blood Pressure Therapy.
The aim of this study was to adapt and to test the reliability of the Polish version of Hill-Bone Compliance to High
Blood Pressure Therapy Scale.
Methods: A standard guideline was used for the translation and cultural adaptation of the English version of the
Hill-Bone Compliance to High Blood Pressure Therapy Scale into Polish. The study included 117 Polish patients with
hypertension aged between 27 and 90 years, among them 53 men and 64 women. Cronbach’s alpha was used for
analysing the internal consistency of the scale.
Results: The mean score in the reduced sodium intake subscale was M = 5.7 points (standard deviation SD = 1.6
points). The mean score in the appointment-keeping subscale was M = 3.4 points (standard deviation SD = 1.4
points). The mean score in the medication-taking subscale was M = 11.6 points (standard deviation SD = 3.3 points).
In the principal component analysis, the three-factor system (1 – medication-taking, 2 – appointment-keeping, 3 –
reduced sodium intake) accounted for 53 % of total variance. All questions had factor loadings > 0.4. The
medication-taking subscale: most questions (6 out of 9) had the highest loadings with Factor 1. The appointment-
keeping subscale: all questions (2 out of 2) had the highest loadings with Factor 2. The reduced sodium intake
subscale: most questions (2 out of 3) had the highest loadings with Factor 3. Goodness of fit was tested at
chi2 = 248.87; p < 0.001. The Cronbach’s alpha score for the entire questionnaire was 0.851.
Conclusion: The Hill-Bone Compliance to High Blood Pressure Therapy Scale proved to be suitable for use in
the Polish population. Use of this screening tool for the assessment of adherence to BP treatment is
recommended.
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Background
Hypertension, or high blood pressure (HBP), is consid-
ered the most common disorder in the general popula-
tion. The World Health Organization (WHO) Report for
2008 states that 40 % of the world’s population over the
age of 25 have high blood pressure [1]. Worldwide, HBP
affects over 1.5 billion people, in Poland – approximately
8.6 million, i.e. 29 % of adults. According to estimates, in
2025, over 2 billion people will suffer from HBP [2].
Despite the wealth of knowledge and the advances in
pharmaceutical treatment and hypotensive drugs, the ef-
fectiveness of HBP treatment in Poland is as low as 5–
15 % [3]. Non-adherence to medications is considered
one of the largest related issues [4, 5]. Several methods
can be used to test compliance and adherence, including
pharmacological, clinical and physical ones. The first
method consists of determining the concentrations of
drugs or their metabolites in serum or in urine. The
clinical methods are based on monitoring follow-up
appointment-keeping. It is assumed that patients who
are cooperative and follow their physicians’ advice tend
to keep their follow-up appointments. The remaining
methods used for determining adherence and compli-
ance are physical ones, consisting in counting the tablets
taken or using tablet-counting systems. These methods
are not, however, reliable, as the presentation of an
empty medicine package to the physician is no proof
that all the doses were taken as prescribed. Patients may
deliberately dispose of the medicine, which artificially in-
creases the score [6–8]. Remote observation is an im-
portant aspect of compliance and adherence assessment
among patients with HBP. After starting pharmaceutical
treatment, follow-up visits should take place every 2–
4 weeks to enable assessment of the drugs’ effectiveness
and any side effects. Once blood pressure falls to the de-
sired values, these follow-ups may be planned at longer
intervals, every few months [9–11]. Every 2 years, all pa-
tients should be checked for risk factors and end-organ
complications of HBP [12]. Physicians‘lack of knowledge
and patients‘lack of awareness account for about 70 % of
non-adherence, indicating the necessity to improve
physician education and patient involvement [13, 14].
Therefore, the researchers work on simple instruments
to assess compliance and adherence to treatment in this
group of patients. One such instrument, increasing in
popularity worldwide, is the Hill-Bone Compliance to
High Blood Pressure Therapy Scale [15]. In its current
version, the Hill-Bone Compliance to High Blood Pres-
sure Therapy Scale comprises 14 questions that are
grouped in the following sub-scales: reduced sodium in-
take (three items), appointment-keeping (two items),
and medication-taking (nine items) [15]. The instrument
has successfully passed validation and psychometric evalu-
ation in many populations and cultures, and has undergone
multiple translations and adaptations [16–19]. We decided
to perform a cultural Polish adaptation of the Hill-Bone
Compliance to High Blood Pressure Therapy Scale ques-
tionnaire and to validate it in a group of HBP patients. This
paper presents the results of our validation study.
Methods
Questionnaire
The Polish adaptation of the Hill-Bone Compliance to High
Blood Pressure Therapy Scale (HBCS)
The adaptation was performed using the standard meth-
odology [20]. The Polish adaptation is based on the
English-language version of the scale (Table 1) [15].
Having received the authors’ approval, the questionnaire
was translated into Polish by two independent transla-
tors. Then, the translations were evaluated by a panel of
experts, which comprised a cardiologist, a general practi-
tioner, two specialist cardiology nurses and a psycholo-
gist. The panel verified the phrasing and meaning of all
questions, as well as the clarity and correctness of the
instructions. The version selected by the panel subse-
quently underwent back-translation and the result was
submitted for approval by the authors of the original
English version. Once approved, the preliminary version
was used in a pilot study on a group of 30 patients diag-
nosed with HBP. The pilot study resulted in the final
Polish version of the Hill-Bone Compliance to High
Table 1 The Hill-Bone Compliance to HBP Therapy Scale – the
original English version
No. Item Response:
1. All of the time 2. Most of the time 3. Some of the
time 4. Never
1 How often do you forget to take your HBP medicine?
2 How often do you decide NOT to take your HBP medicine?
3 How often do you eat salty food?
4 How often do you add salt to your food before you eat it?
5 How often do you eat fast food?
6 How often do you make the next appointment before you
leave the doctor’s office?*
7 How often do you miss scheduled appointments?
8 How often do you forget to get prescriptions filled?
9 How often do you run out of HBP pills?
10 How often do you skip your HBP medicine before you go to
the doctor?
11 How often do you miss taking your HBP pills when you
feel better?
12 How often do you miss taking your HBP pills when you
feel sick?
13 How often do you take someone else’s HBP pills?
14 How often do you miss taking your HBP pills when you are
careless?
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Blood Pressure Therapy Scale, validated in the present
study.
Patients
The study was carried out at a private medical center in
Wrocław, between March and September, 2015, and in-
cluded 117 sequential patients diagnosed with HBP in
accordance with the ESC criteria. The patients filled in
the questionnaire during a regular follow-up visit. The
refusal rate was 0 %, and the acceptance rate was 100 %.
The only exclusion criterion was cognitive impairment
and/or communication barriers interfering with ques-
tionnaire completion. The sample size was based on lit-
erature data, indicating that the minimum number of
participants in a validation study should be five times
the number of variables analyzed [21]. Therefore, a val-
idation study of the Hill-Bone Compliance to High
Blood Pressure Therapy Scale should include a mini-
mum of 70 patients (5 × 14 statements). It was the repre-
sentative sample of hypertensive patients in Poland, so it
might be generalized to other patients. All patients gave
informed written consent to participate in writing, and
the study protocol was approved by the Independent
Bioethics Committee of the Wrocław Medical University
(decision no. KB 136/2015).
Statistical analysis
The results obtained were analyzed using Statistica 10
software (StatSoft, Tulsa, USA). The normality of
variable distribution was verified using the Kolmogorov–
Smirnov test, and the statistical characteristics of
variables were presented using arithmetical means ±
standard deviations (SD), median values and interquar-
tile ranges (IQR). The statistical characteristics of
discrete and qualitative variables were presented using
number distributions (n). The internal consistency and
the intraclass correlation coefficients of the Polish adap-
tation were assessed based on Cronbach’s alpha.
Results
The socio-demographic and clinical characteristics of
the 117 patients studied are summarized in Table 2. The
sample included 53 men (45.30 %) and 64 women
(54.70 %). The mean age was 60.7 years (SD 12.41).
Most patients were married or living with a partner
(66.67 %) and high-school educated (51.28 %). The mean
time from diagnosis was 9.18 years (SD 7.4). The
number of tablets taken daily was 2.61 (SD 3.26). The
detailed characteristics of the patients are shown in
Table 2. The Table 3 shows descriptive statistics from
the Hill-Bone Compliance to High Blood Pressure Ther-
apy Scale in the studied group.
The mean sodium intake score among the patients
studied was M = 5.7 points (standard deviation SD = 1.6
points). The mean appointment-keeping score in the
group was M = 3.4 points (standard deviation SD = 1.4
points). The mean medicine-taking score was M = 11.6
points (standard deviation SD = 3.3 points).
The scale’s construct validity
The principal components of the HBSC scale were
analyzed. The three-factor system (variables: 1 –
medication-taking, 2 – appointment-keeping, 3 – re-
duced sodium intake) accounts for 53 % of total
variance. All questions have factor loadings >0.4. The
medication-taking subscale: most questions (6 out of 9)
have the highest loadings with Factor 1. The
appointment-keeping subscale: all questions (2 out of 2)
have the highest loadings with Factor 2. The reduced
sodium intake subscale: most questions (2 out of 3)
have the highest loadings with Factor 3. Goodness of fit
was tested at chi2 = 248.87; p < 0.001 (Table 4). The in-
strument shows appropriate construct validity and no
questions need to be excluded.
Table 2 Patients' socio-demographic and clinical data





M ± SD 60.77 ± 12.41
Min ÷ Max 27 ÷ 90
Marital status
Married/living with a partner 78 66.67
Single 39 33.33
Education
None or primary 32 27.35
High school 60 51.28
Higher vocational/College/University 25 21.37
Blood pressure value Systolic Diastolic
M ± SD 144.14 ± 13.69 87.85 ± 11.36
Min ÷ Max 120 ÷190 60 ÷ 120
Time from HBP diagnosis
M ± SD 9.18 ± 7.4
Min ÷ Max 1 ÷10
JNC blood pressure classification
Stage 1 hypertension 63 53.85
Stage 2 hypertension 36 30.77
Prehypertension 18 15.38
n number, M± SD mean ± standard deviation, Min ÷ Max minimum ÷
maximum, HBP high blood pressure, JNC Joint National Committee
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The scale’s criterion validity
Analysis of correlation with external criteria (systolic
and diastolic blood pressure) – Spearman’s rank correl-
ation coefficients (Table 5). The instrument has unique
criterion validity, which is a complement to the blood
pressure measurement and not its substitute.
Scale reliability
Internal consistency was tested using Cronbach’s alpha,
and the intraclass correlation coefficient was determined.
The Cronbach’s alpha score for the whole questionnaire
was 0.80, and for the medicine-taking subscale it was
0.78. Cronbach’s alpha was not calculated for the
remaining subscales due to the insufficient number of
questions. Coefficients of correlation with the total score
ranged from 0.14 (question 3) to 0.653 (question 10).
The intraclass correlation coefficient for the whole ques-
tionnaire was 0.851 (Table 6).
Discussion
The aim of the study was to prepare a Polish adaptation
of the Hill-Bone Compliance to High Blood Pressure
Therapy Scale and to validate the instrument in a group
of HBP patients. The Hill-Bone Compliance to High
Blood Pressure Therapy Scale showed sufficient psycho-
metric quality in different aspects of acceptability,
reliability and validity. The validation was based on
determining a routine psychometric characteristic –
Cronbach’s alpha, measuring the instrument’s internal
consistency. The internal consistency of the Polish adap-
tation of the Hill-Bone Compliance to High Blood Pres-
sure Therapy Scale was tested at 0.851. This value is
similar to the original instrument’s internal consistency
and to values obtained in validation studies of other lan-
guage versions and cultural adaptations performed in
Turkey (0.72) [15, 16], South Africa (0.77) [17] and
Germany (0.73) [18]. However, in the adaptation by
Krauser-Wood et al. it was found that the scale has suffi-
cient internal consistency and factorial construct validity
only for the medication-taking subscale [19]. Therefore,
the authors recommend studying adherence using only
this subscale (Hill-Bone Scale Short Form – SF). In the
Polish adaptation, the Hill-Bone Scale was shown to
have sufficient construct and criterion validity, which
means HBSC scores were predictive of BP outcomes and
were significantly correlated with other theoretically se-
lected variables. The HBP scale also demonstrated high
internal consistency when used in South Africa or when
Table 3 Descriptive statistics from the Hill-Bone Compliance to High Blood Pressure Therapy Scale in the studied group
Question M ± SD All the time [%] Most of the time [%] Sometimes [%] Never [%]
3 How often do you eat salty food? 2.41 ± 0.76 6.84 53.85 29.06 9.40
4 How often do you add salt to your food before you eat it? 1.93 ± 0.85 35.04 41.03 19.66 4.27
5 How often do you eat fast food? 1.40 ± 0.61 63.25 29.06 3.42 0.85
Reduced sodium intake 5.68 ± 1.60
6 How often do you make the next appointment before you
leave the doctor’s office?
2.75 ± 1.05 11.97 29.06 22.22 29.91
7 How often do you miss scheduled appointments? 1.30 ± 0.61 74.36 19.66 2.56 1.71
Appointment-keeping 3.41 ± 1.45
1 How often do you forget to take your HBP medicine? 1.39 ± 0.64 67.52 26.50 3.42 1.71
2 Jak często decyduje się Pan/Pani nie brać leków na
nadciśnienie? [How often do you decide NOT to take
your HBP medicine?]
1.35 ± 0.62 70.94 21.37 5.13 0.85
8 How often do you forget to get prescriptions filled? 1.30 ± 0.50 70.94 25.64 1.71 0.00
9 How often do you run out of HBP pills? 1.42 ± 0.56 60.68 34.19 3.42 0.00
10 How often do you skip your HBP medicine before you
go to the doctor?
1.25 ± 0.43 72.65 23.93 0.00 0.00
1 How often do you miss taking your HBP pills when
you feel better?
1.39 ± 0.68 68.38 26.50 0.85 3.42
12 How often do you miss taking your HBP pills when
you feel sick?
1.33 ± 0.60 71.79 21.37 4.27 0.85
13 How often do you take someone else’s HBP pills? 1.17 ± 0.53 86.32 7.69 1.71 1.71
14 How often do you miss taking your HBP pills when
you are careless?
1.25 ± 0.53 77.78 16.24 4.27 0.00
Medicine-taking 11.62 ± 3.32
HBP high blood pressure, M± SD mean ± standard deviation
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translated into Turkish [16, 17]. As to the interpretation
of the results obtained, it should be emphasized that the
psychometric qualities of the Polish adaptation of the
Hill-Bone Compliance to High Blood Pressure Therapy
Scale are superior to those obtained in other language
versions and cultural adaptations. For example, the
German validation of the HBP scale showed floor effects
and poor ability to predict medication adherence for
nearly every third participant [18]. According to some
authors, the optimum internal consistency is indicated
by Cronbach’s alpha at ≥0.90; values ≥0.80 are considered
good, ≥ 0.70 – acceptable, ≥ 0.60 – questionable, ≥ 0.50
– poor and <0.50 – unacceptable [22]. Therefore, the
Polish adaptation of the Hill-Bone Compliance to High
Blood Pressure Therapy Scale questionnaire can be con-
sidered an instrument with good psychometric qualities.
A reliable and valid adherence measurement based on
the patient’s self-report may be helpful in daily practice.
Conclusions
The Hill-Bone Compliance to High Blood Pressure Ther-
apy Scale proved to be suitable for use in the Polish popu-
lation. The use of this screening tool for the assessment of
adherence to BP treatment is recommended.
Ethics approval and consent to participate
The study protocol was approved by the Independent
Bioethics Committee of the Wroclaw Medical University
(decision no. KB 136/2015). All participants gave written
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Table 4 Factor loadings for each question in the questionnaire
Question Factor 1 Factor 2 Factor 3
Question_2 0.35 −0.04 0.20
Question_5 0.51 0.22 0.41
Question_8 0.59 0.29 0.07
Question_9 0.83 0.08 0.05
Question_11 0.88 0.16 −0.04
Question_12 0.67 0.18 0.09
Question_13 0.47 0.01 0.09
Question_1 0.11 0.80 0.02
Question_6 −0.22 0.44 0.38
Question_7 0.54 0.65 −0.07
Question_10 0.31 0.72 0.30
Question_14 0.05 0.76 −0.09
Question_3 0.11 −0.15 0.71
Question_4 −0.05 0.17 0.74
Expl.Var 3.33 2.61 1.55
Prp.Totl 0.24 0.19 0.11
1-How often do you forget to take your HBP medicine? 2-How often do you
decide NOT to take your HBP medicine? 3-How often do you eat salty food?
4-How often do you add salt to your food before you eat it? 5-How often do
you eat fast food? 6-How often do you make the next appointment before
you leave the doctor’s office? 7-How often do you miss scheduled
appointments? 8-How often do you forget to get prescriptions filled? 9-How
often do you run out of HBP pills? 10-How often do you skip your HBP
medicine before you go to the doctor? 11-How often do you miss taking your
HBP pills when you feel better? 12-How often do you miss taking your HBP
pills when you feel sick? 13-How often do you take someone else’s HBP pills?
14-How often do you miss taking your HBP pills when you are careless?
Table 5 Spearman's rank correlation coefficients for the scale
total and the medication taking subscale score on the one
hand, and systolic and diastolic blood pressure on the other
Variable Systolic blood pressure Diastolic blood pressure
R p-value R p-value
Medicine taking −0.039 0.679 −0.015 0.873
Total score 0.017 0.859 0.049 0.599
R – Spearman's rank correlation coefficient; p-value – statistical significance
coefficient
Table 6 Internal consistency and intraclass correlation









Question 1 0.471 0.768 0.842
Question 2 0.209 0.788 0.852
Question 3 0.140 0.791 0.820
Question 4 0.230 0.784 0.886
Question 5 0.541 0.758 0.830
Question 6 0.157 0.808 0.826
Question 7 0.599 0.756 0.787
Question 8 0.505 0.765 0.807
Question 9 0.543 0.761 0.855
Question 10 0.653 0.746 0.840
Question 11 0.582 0.760 0.888
Question 12 0.504 0.763 0.861
Question 13 0.320 0.780 0.807
Question 14 0.380 0.774 0.806
1-How often do you forget to take your HBP medicine? 2-How often do you
decide NOT to take your HBP medicine? 3-How often do you eat salty food?
4-How often do you add salt to your food before you eat it? 5-How often do
you eat fast food? 6-How often do you make the next appointment before
you leave the doctor’s office? 7-How often do you miss scheduled
appointments? 8-How often do you forget to get prescriptions filled? 9-How
often do you run out of HBP pills? 10-How often do you skip your HBP
medicine before you go to the doctor? 11-How often do you miss taking your
HBP pills when you feel better? 12-How often do you miss taking your HBP
pills when you feel sick? 13-How often do you take someone else’s HBP pills?
14-How often do you miss taking your HBP pills when you are careless?
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